Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Current Assets (2016 - 2025)

Cumberland Pharmaceuticals' Current Assets history spans 16 years, with the latest figure at $37.1 million for Q4 2025.

  • For Q4 2025, Current Assets rose 1.67% year-over-year to $37.1 million; the TTM value through Dec 2025 reached $37.1 million, up 1.67%, while the annual FY2025 figure was $37.1 million, 1.67% up from the prior year.
  • Current Assets for Q4 2025 was $37.1 million at Cumberland Pharmaceuticals, up from $29.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $49.4 million in Q1 2021 and bottomed at $29.9 million in Q3 2025.
  • The 5-year median for Current Assets is $43.7 million (2023), against an average of $40.8 million.
  • The largest annual shift saw Current Assets increased 10.39% in 2021 before it dropped 18.53% in 2024.
  • A 5-year view of Current Assets shows it stood at $45.7 million in 2021, then grew by 0.4% to $45.9 million in 2022, then fell by 8.94% to $41.8 million in 2023, then fell by 12.73% to $36.5 million in 2024, then rose by 1.67% to $37.1 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Current Assets are $37.1 million (Q4 2025), $29.9 million (Q3 2025), and $31.2 million (Q2 2025).